Amniotic membrane transplantation with or without autologous cultivated limbal stem cell transplantation for the management of partial limbal stem cell deficiency

Namrata Sharma,1 Sujata Mohanty,2 Vishal Jhanji,3,4 Rasik B Vajpayee4–6 1Cornea, Cataract and Refractive Surgery Services, Dr Rajendra Prasad Center for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India; 2Stem Cell Facility DBT – Centre of Excellence...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sharma N, Mohanty S, Jhanji V, Vajpayee RB
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/b64eee9a77f04c3ca46a22595e949275
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b64eee9a77f04c3ca46a22595e949275
record_format dspace
spelling oai:doaj.org-article:b64eee9a77f04c3ca46a22595e9492752021-12-02T11:21:06ZAmniotic membrane transplantation with or without autologous cultivated limbal stem cell transplantation for the management of partial limbal stem cell deficiency1177-5483https://doaj.org/article/b64eee9a77f04c3ca46a22595e9492752018-10-01T00:00:00Zhttps://www.dovepress.com/amniotic-membrane-transplantation-with-or-without-autologous-cultivate-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Namrata Sharma,1 Sujata Mohanty,2 Vishal Jhanji,3,4 Rasik B Vajpayee4–6 1Cornea, Cataract and Refractive Surgery Services, Dr Rajendra Prasad Center for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India; 2Stem Cell Facility DBT – Centre of Excellence for Stem Cell Research, All India Institute of Medical Sciences, New Delhi, India; 3Cornea, Cataract and External Disease Services, Refractive Surgery Service, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; 4Centre for Eye Research Australia, University of Melbourne, Melbourne, Australia; 5Royal Victorian Eye and Ear Hospital, Melbourne, Australia; 6Cornea, Cataract & Refractive Surgery Services, Vision Eye Institute, Melbourne, Australia Purpose: To compare the outcomes of amniotic membrane transplantation (AMT) vs cultivated limbal stem cell transplantation (LSCT) in eyes with partial limbal stem cell deficiency (LSCD) following chemical burns.Methods: Eyes with unilateral partial LSCD (≤180° involvement) were randomized in two groups to undergo either pannus resection combined with AMT or pannus resection combined with LSCT in a tertiary eye care hospital. Primary outcome measures were time to corneal epithelialization and absence of conjunctivalization of the cornea. Patients were followed up at 1 week, 1, 3, 6, and 12 months after the surgical procedure.Results: There was no difference between mean age (30.85±5.8 vs 28.64±6.4 years, P=0.40) and sex distribution of patients between the two groups at baseline. Mean time to corneal epithelialization was 10.45±5.8 days in the AMT group and 11±3.9 days in the LSCT group (P=0.43). At the end of 1 year, there was no significant difference between the degree of conjunctivalization of cornea, (P=0.06) corneal vascularization, (P=0.08), and clarity (P=0.07) in both groups.Conclusion: Our study showed that AMT alone is a useful therapeutic modality in cases with partial LSCD due to ocular chemical injury. Stem cell transplantation may not be required in these cases. Keywords: partial LSCD, amniotic membrane transplantation, limbal stem cell transplantationSharma NMohanty SJhanji VVajpayee RBDove Medical Pressarticlepartial LSCDamniotic membrane transplantationLimbal stem cell transplantationOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 12, Pp 2103-2106 (2018)
institution DOAJ
collection DOAJ
language EN
topic partial LSCD
amniotic membrane transplantation
Limbal stem cell transplantation
Ophthalmology
RE1-994
spellingShingle partial LSCD
amniotic membrane transplantation
Limbal stem cell transplantation
Ophthalmology
RE1-994
Sharma N
Mohanty S
Jhanji V
Vajpayee RB
Amniotic membrane transplantation with or without autologous cultivated limbal stem cell transplantation for the management of partial limbal stem cell deficiency
description Namrata Sharma,1 Sujata Mohanty,2 Vishal Jhanji,3,4 Rasik B Vajpayee4–6 1Cornea, Cataract and Refractive Surgery Services, Dr Rajendra Prasad Center for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India; 2Stem Cell Facility DBT – Centre of Excellence for Stem Cell Research, All India Institute of Medical Sciences, New Delhi, India; 3Cornea, Cataract and External Disease Services, Refractive Surgery Service, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; 4Centre for Eye Research Australia, University of Melbourne, Melbourne, Australia; 5Royal Victorian Eye and Ear Hospital, Melbourne, Australia; 6Cornea, Cataract & Refractive Surgery Services, Vision Eye Institute, Melbourne, Australia Purpose: To compare the outcomes of amniotic membrane transplantation (AMT) vs cultivated limbal stem cell transplantation (LSCT) in eyes with partial limbal stem cell deficiency (LSCD) following chemical burns.Methods: Eyes with unilateral partial LSCD (≤180° involvement) were randomized in two groups to undergo either pannus resection combined with AMT or pannus resection combined with LSCT in a tertiary eye care hospital. Primary outcome measures were time to corneal epithelialization and absence of conjunctivalization of the cornea. Patients were followed up at 1 week, 1, 3, 6, and 12 months after the surgical procedure.Results: There was no difference between mean age (30.85±5.8 vs 28.64±6.4 years, P=0.40) and sex distribution of patients between the two groups at baseline. Mean time to corneal epithelialization was 10.45±5.8 days in the AMT group and 11±3.9 days in the LSCT group (P=0.43). At the end of 1 year, there was no significant difference between the degree of conjunctivalization of cornea, (P=0.06) corneal vascularization, (P=0.08), and clarity (P=0.07) in both groups.Conclusion: Our study showed that AMT alone is a useful therapeutic modality in cases with partial LSCD due to ocular chemical injury. Stem cell transplantation may not be required in these cases. Keywords: partial LSCD, amniotic membrane transplantation, limbal stem cell transplantation
format article
author Sharma N
Mohanty S
Jhanji V
Vajpayee RB
author_facet Sharma N
Mohanty S
Jhanji V
Vajpayee RB
author_sort Sharma N
title Amniotic membrane transplantation with or without autologous cultivated limbal stem cell transplantation for the management of partial limbal stem cell deficiency
title_short Amniotic membrane transplantation with or without autologous cultivated limbal stem cell transplantation for the management of partial limbal stem cell deficiency
title_full Amniotic membrane transplantation with or without autologous cultivated limbal stem cell transplantation for the management of partial limbal stem cell deficiency
title_fullStr Amniotic membrane transplantation with or without autologous cultivated limbal stem cell transplantation for the management of partial limbal stem cell deficiency
title_full_unstemmed Amniotic membrane transplantation with or without autologous cultivated limbal stem cell transplantation for the management of partial limbal stem cell deficiency
title_sort amniotic membrane transplantation with or without autologous cultivated limbal stem cell transplantation for the management of partial limbal stem cell deficiency
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/b64eee9a77f04c3ca46a22595e949275
work_keys_str_mv AT sharman amnioticmembranetransplantationwithorwithoutautologouscultivatedlimbalstemcelltransplantationforthemanagementofpartiallimbalstemcelldeficiency
AT mohantys amnioticmembranetransplantationwithorwithoutautologouscultivatedlimbalstemcelltransplantationforthemanagementofpartiallimbalstemcelldeficiency
AT jhanjiv amnioticmembranetransplantationwithorwithoutautologouscultivatedlimbalstemcelltransplantationforthemanagementofpartiallimbalstemcelldeficiency
AT vajpayeerb amnioticmembranetransplantationwithorwithoutautologouscultivatedlimbalstemcelltransplantationforthemanagementofpartiallimbalstemcelldeficiency
_version_ 1718396010743463936